New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
New breakthrough in the treatment of rheumatoid arthritis

New breakthrough in the treatment of rheumatoid arthritis

by University of OxfordCredit: University of OxfordPeople with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly
Immunology & Rheumatology May 13,2024
New breakthrough in the treatment of rheumatoid arthritis

New breakthrough in the treatment of rheumatoid arthritis

by University of OxfordCredit: University of OxfordPeople with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly
Immunology & Rheumatology May 13,2024
Holding mycophenolate mofetil for 10 days or more may improve COVID-19 vaccine response

Holding mycophenolate mofetil for 10 days or more may improve COVID-19 vaccine response

by American College of RheumatologyAnti-spike antibody response following two dose SARS-CoV_2 vaccine dose in RMD, stratified by peri-vaccination mycophenolate hold duration. Credit: Increased Du
Immunology & Rheumatology May 13,2024
Holding mycophenolate mofetil for 10 days or more may improve COVID-19 vaccine response

Holding mycophenolate mofetil for 10 days or more may improve COVID-19 vaccine response

by American College of RheumatologyAnti-spike antibody response following two dose SARS-CoV_2 vaccine dose in RMD, stratified by peri-vaccination mycophenolate hold duration. Credit: Increased Du
Immunology & Rheumatology May 13,2024
Study finds opioids double risk of venous thromboembolism in rheumatoid arthritis patients

Study finds opioids double risk of venous thromboembolism in rheumatoid arthritis patients

by American College of RheumatologyRisk of outcomes (HR, 95% CI) with opioid initiation compared to NSAID initiation after adjustment for propensity score weights and imbalanced covariables (CVD
Immunology & Rheumatology May 13,2024
Study finds opioids double risk of venous thromboembolism in rheumatoid arthritis patients

Study finds opioids double risk of venous thromboembolism in rheumatoid arthritis patients

by American College of RheumatologyRisk of outcomes (HR, 95% CI) with opioid initiation compared to NSAID initiation after adjustment for propensity score weights and imbalanced covariables (CVD
Immunology & Rheumatology May 13,2024
Rejuvenation of aging cells helps to cure osteoarthritis through gene therapy

Rejuvenation of aging cells helps to cure osteoarthritis through gene therapy

by Chinese Academy of SciencesCBX4 maintains nucleolar homeostasis, alleviates senescence and osteoarthritis. Credit: IOZAging is a risk factor for the development of osteoarthritis (OA), a chron
Immunology & Rheumatology May 13,2024
Rejuvenation of aging cells helps to cure osteoarthritis through gene therapy

Rejuvenation of aging cells helps to cure osteoarthritis through gene therapy

by Chinese Academy of SciencesCBX4 maintains nucleolar homeostasis, alleviates senescence and osteoarthritis. Credit: IOZAging is a risk factor for the development of osteoarthritis (OA), a chron
Immunology & Rheumatology May 13,2024
Those suffering from autoimmune diseases require a third coronavirus vaccination

Those suffering from autoimmune diseases require a third coronavirus vaccination

by Friedrich–Alexander University Erlangen–NurnbergCredit: Pixabay/CC0 Public DomainMany patients suffering from an autoimmune disease such as rheumatism, ulcerative colitis or psoriasis must tak
Immunology & Rheumatology May 13,2024
Those suffering from autoimmune diseases require a third coronavirus vaccination

Those suffering from autoimmune diseases require a third coronavirus vaccination

by Friedrich–Alexander University Erlangen–NurnbergCredit: Pixabay/CC0 Public DomainMany patients suffering from an autoimmune disease such as rheumatism, ulcerative colitis or psoriasis must tak
Immunology & Rheumatology May 13,2024
Smoking cessation may reduce risk of rheumatoid arthritis

Smoking cessation may reduce risk of rheumatoid arthritis

by Brigham and Women's HospitalCredit: CC0 Public DomainSmoking is an important risk factor for developing the most common form of rheumatoid arthritis (RA) and other inflammatory diseases, b
Immunology & Rheumatology May 13,2024
Smoking cessation may reduce risk of rheumatoid arthritis

Smoking cessation may reduce risk of rheumatoid arthritis

by Brigham and Women's HospitalCredit: CC0 Public DomainSmoking is an important risk factor for developing the most common form of rheumatoid arthritis (RA) and other inflammatory diseases, b
Immunology & Rheumatology May 13,2024
Q and A: Spinal arthritis

Q and A: Spinal arthritis

by Cynthia Weiss, Gazanfar RahmathullaCredit: Pixabay/CC0 Public DomainI am in my late 50s and have started having stiffness in my back. I have become much less flexible and sometimes even have a hard
Q & A May 13,2024
Q and A: Spinal arthritis

Q and A: Spinal arthritis

by Cynthia Weiss, Gazanfar RahmathullaCredit: Pixabay/CC0 Public DomainI am in my late 50s and have started having stiffness in my back. I have become much less flexible and sometimes even have a hard
Q & A May 13,2024
Osteoarthritis biomarker could help cut $23 billion health bill

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful
Immunology & Rheumatology May 13,2024
Osteoarthritis biomarker could help cut $23 billion health bill

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful
Immunology & Rheumatology May 13,2024
Having hypermobile joints may increase the risk for depression and anxiety in adolescents

Having hypermobile joints may increase the risk for depression and anxiety in adolescents

by University of SussexPrevalence of generalized joint hypermobility. (A) Shows the difference in prevalence of GJH in participants who meet diagnostic criteria for ICD-10 depression (blue bar) a
Immunology & Rheumatology May 13,2024
Having hypermobile joints may increase the risk for depression and anxiety in adolescents

Having hypermobile joints may increase the risk for depression and anxiety in adolescents

by University of SussexPrevalence of generalized joint hypermobility. (A) Shows the difference in prevalence of GJH in participants who meet diagnostic criteria for ICD-10 depression (blue bar) a
Immunology & Rheumatology May 13,2024
Screening of patients with rheumatism improves insight into cardiovascular disease

Screening of patients with rheumatism improves insight into cardiovascular disease

by University of TwenteSince the fifties, researchers have observed that patients with rheumatoid arthritis have an increased mortality from cardiovascular disease. Patients with this form of rhe
Immunology & Rheumatology May 13,2024
Screening of patients with rheumatism improves insight into cardiovascular disease

Screening of patients with rheumatism improves insight into cardiovascular disease

by University of TwenteSince the fifties, researchers have observed that patients with rheumatoid arthritis have an increased mortality from cardiovascular disease. Patients with this form of rhe
Immunology & Rheumatology May 13,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com